A detailed history of Letko, Brosseau & Associates Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Letko, Brosseau & Associates Inc holds 234,239 shares of MRK stock, worth $26.6 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
234,239
Previous 259,419 9.71%
Holding current value
$26.6 Million
Previous $34.2 Million 15.28%
% of portfolio
0.57%
Previous 0.61%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

SELL
$123.8 - $132.96 $3.12 Million - $3.35 Million
-25,180 Reduced 9.71%
234,239 $29 Million
Q1 2024

May 08, 2024

SELL
$113.24 - $131.95 $229,877 - $267,858
-2,030 Reduced 0.78%
259,419 $34.2 Million
Q4 2023

Feb 12, 2024

SELL
$100.18 - $109.02 $777,396 - $845,995
-7,760 Reduced 2.88%
261,449 $28.5 Million
Q3 2023

Nov 09, 2023

SELL
$102.95 - $114.33 $318,115 - $353,279
-3,090 Reduced 1.13%
269,209 $27.7 Million
Q2 2023

Aug 10, 2023

SELL
$108.61 - $118.38 $1.94 Million - $2.11 Million
-17,835 Reduced 6.15%
272,299 $31.4 Million
Q1 2023

May 11, 2023

SELL
$102.94 - $114.86 $5 Million - $5.58 Million
-48,575 Reduced 14.34%
290,134 $30.9 Million
Q4 2022

Feb 10, 2023

SELL
$87.44 - $112.11 $18 Million - $23.1 Million
-206,012 Reduced 37.82%
338,709 $37.6 Million
Q3 2022

Nov 10, 2022

SELL
$84.53 - $94.96 $774,971 - $870,593
-9,168 Reduced 1.66%
544,721 $46.9 Million
Q2 2022

Aug 09, 2022

SELL
$83.49 - $94.64 $7.17 Million - $8.13 Million
-85,870 Reduced 13.42%
553,889 $50.5 Million
Q1 2022

May 11, 2022

SELL
$73.51 - $82.4 $856,170 - $959,712
-11,647 Reduced 1.79%
639,759 $52.5 Million
Q4 2021

Feb 09, 2022

SELL
$72.28 - $90.54 $856,879 - $1.07 Million
-11,855 Reduced 1.79%
651,406 $49.9 Million
Q3 2021

Nov 03, 2021

SELL
$71.68 - $78.83 $2.4 Million - $2.63 Million
-33,425 Reduced 4.8%
663,261 $49.8 Million
Q2 2021

Jul 29, 2021

SELL
$70.31 - $77.77 $441,546 - $488,395
-6,280 Reduced 0.89%
696,686 $54.2 Million
Q1 2021

May 11, 2021

SELL
$68.86 - $81.11 $1.26 Million - $1.48 Million
-18,262 Reduced 2.53%
702,966 $54.2 Million
Q4 2020

Feb 05, 2021

SELL
$71.77 - $79.65 $5.06 Million - $5.61 Million
-70,435 Reduced 8.9%
721,228 $59 Million
Q3 2020

Nov 09, 2020

SELL
$73.18 - $82.95 $5.9 Million - $6.69 Million
-80,665 Reduced 9.25%
791,663 $65.7 Million
Q2 2020

Aug 07, 2020

SELL
$70.42 - $80.13 $3.67 Million - $4.17 Million
-52,050 Reduced 5.63%
872,328 $67.5 Million
Q1 2020

May 14, 2020

SELL
$63.36 - $87.82 $94,406 - $130,851
-1,490 Reduced 0.16%
924,378 $71.1 Million
Q4 2019

Feb 07, 2020

SELL
$77.58 - $87.54 $4.23 Million - $4.78 Million
-54,555 Reduced 5.56%
925,868 $84.2 Million
Q3 2019

Nov 05, 2019

SELL
$76.08 - $82.93 $4.23 Million - $4.61 Million
-55,560 Reduced 5.36%
980,423 $82.5 Million
Q2 2019

Aug 01, 2019

SELL
$69.84 - $81.59 $5.87 Million - $6.86 Million
-84,020 Reduced 7.5%
1,035,983 $86.9 Million
Q1 2019

May 10, 2019

SELL
$69.58 - $79.36 $5.71 Million - $6.51 Million
-82,002 Reduced 6.82%
1,120,003 $93.2 Million
Q4 2018

Feb 08, 2019

SELL
$65.24 - $75.71 $24.2 Million - $28 Million
-370,213 Reduced 23.55%
1,202,005 $91.8 Million
Q3 2018

Nov 08, 2018

SELL
$57.69 - $67.84 $45.7 Million - $53.7 Million
-791,945 Reduced 33.5%
1,572,218 $112 Million
Q2 2018

Aug 07, 2018

SELL
$50.83 - $59.72 $1.86 Million - $2.18 Million
-36,575 Reduced 1.52%
2,364,163 $144 Million
Q1 2018

May 08, 2018

BUY
$50.96 - $59.23 $130,712 - $151,924
2,565 Added 0.11%
2,400,738 $131 Million
Q4 2017

Feb 20, 2018

SELL
$51.62 - $61.64 $2.7 Million - $3.23 Million
-52,335 Reduced 2.14%
2,398,173 $135 Million
Q3 2017

Nov 13, 2017

BUY
$58.67 - $63.13 $144 Million - $155 Million
2,450,508
2,450,508 $157 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $288B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Letko, Brosseau & Associates Inc Portfolio

Follow Letko, Brosseau & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Letko, Brosseau & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Letko, Brosseau & Associates Inc with notifications on news.